Valuation Astellas Pharma Inc. OTC Markets

Stocks

Delayed OTC Markets 03:24:04 2026-10-30 pm EDT			5-day change	1st Jan Change
16.17 ^USD	+1.06%		+1.38%	+21.67%

Oct. 28	Astellas Pharma Inc. Enters Exclusive Option and License Agreement with Audax Biosciences Pty Ltd for Dax-044	CI
Oct. 08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	4,609,838	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	2.16%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	4,550,540	4,129,184	3,753,896
Change	-	-6.22%	-13.1%	23.8%	48.4%	-5.14%	-9.26%	-9.09%
P/E	28.5x	34.7x	173x	51x	15.5x	11.7x	12.7x	16.4x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	2.2x	2x	1.9x
PEG	-	-1.8x	-2.1x	0x	0x	0.3x	-1.69x	-0.7x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.94x	2.08x	2.33x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.92x	1.87x	1.9x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.99x	5.83x	6.23x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.92x	8.65x	10.1x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	9.83x	7.51x	7.27x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	10.2%	13.3%	13.8%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.12%	3.23%	3.32%
EPS ²	67.08	54.24	9.51	28.35	162.8	219.5	203	156.5
Distribution rate	74.5%	111%	736%	261%	47.9%	36.5%	40.9%	54.5%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,374,506	2,213,393	1,974,834
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	759,330	707,826	602,722
EBIT ¹	155,686	133,029	25,518	41,039	382,633	510,043	477,613	371,935
Net income ¹	124,086	98,714	17,045	50,747	291,535	377,754	346,056	263,382
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,299	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,571.00	2,571.00	2,571.00
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	464.09B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%